{"document": {"publication": "Tag My News", "full_text": "novartis ag's blood cancer drug inc424 could rake in annual sales of $1 billion, the group's head of oncology told reuters on tuesday, in a boost to the swiss drugmaker's cancer pipeline.", "title": "novartis sees blood cancer drug as blockbuster", "line_count": 1, "filename": "26305", "publication_date": "15-03-2011 18:40:44", "lines_and_colors": [["novartis ag's blood cancer drug inc424 could rake in annual sales of $1 billion, the group's head of oncology told reuters on tuesday, in a boost to the swiss drugmaker's cancer pipeline.", {}]]}}